Accessibility Menu
Tanke Biosciences logo

Tanke Biosciences(OTC) TNBI

Market Cap$461.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)-98%
5 Year-98%
1 Year-44%
1 Month+26%
$0.02
+25.33%
+0.00Today
Tanke Biosciences last closing stock price
MetricPriceDate
Last closeUSD 0.022026-08-21
Tanke Biosciences stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-16.59%USD 0.022026-08-11
1 month+25.5%USD 0.022026-06-02
3 month+25.5%USD 0.022026-05-08
Year to date-28.42%USD 0.032025-12-31
1 year-43.79%USD 0.032025-08-12
3 year-81.23%USD 0.102023-08-08
5 year-98.12%USD 1.002021-08-20
Since inception-98.14%USD 1.012011-06-07

Tanke Biosciences Financials at a Glance

Market Cap

$461.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$195.21K

EPS (TTM)

-$0.01

P/E Ratio

-2.44

Dividend

$0.00

Beta (Volatility)

-0.18 (Low)

Price

$0.02

Volume

10,000

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.02 - $0.06

Estimated Earnings Date

N/A

TNBI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tanke Biosciences

Tanke Biosciences Corporation is focused on developing, producing, and selling a diverse range of animal nutrition and feed additive products. The company operates through various subsidiaries and offers products that cater to livestock and poultry needs, primarily in China, Southeast Asia, and Latin America.

Products and Services
  • Organic trace mineral additives marketed under the Qili brand
  • Qilicid feed acidifiers to prevent microbial spoilage
  • Herbal medicinal additives like Extra-Health and Qilimix
Growth Outlook
  • Expansion into Southeast Asia and Latin America markets is underway
  • Increasing demand for organic and herbal feed additives is noted
  • Focus on innovation in animal nutrition products is prioritized
Financial Highlights
  • Recent quarterly net income reported at -$47,236
  • Trailing twelve months (TTM) revenue remains at $0
  • Current liabilities significantly exceed total assets, indicating financial challenges
Tanke Biosciences Corporation has established itself in the animal nutrition sector with a comprehensive product lineup. The company’s focus on organic and herbal solutions aligns with growing market trends favoring sustainable and health-conscious animal feed. Despite facing financial challenges, including a negative net income and high current liabilities, the company is positioned to leverage its innovative product offerings and expand into new markets. The ongoing demand for quality animal nutrition products presents potential growth opportunities, making Tanke Biosciences a company to watch in the evolving agricultural landscape.
AI Generated • Aug 20, 2026

Industry

Commercial Services and Supplies

Sector

Industrials

CEO

Vincent W. Renz, Jr., MBA

Website

www.tanke-bio.com

Headquarters

Las Vegas, NV 89128, US

TNBI Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

46.76%

Return on Capital

N/A

Return on Assets

-269.52%

Earnings Yield

-40.98%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$461.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

24.54M

Volume

10.00K

Avg. Volume

2.05K

Financials (TTM)

Gross Profit

-$391.00

Operating Income

-$184.62K

EBITDA

-$184.23K

Operating Cash Flow

-$25.40K

Capital Expenditure

$7.84

Free Cash Flow

-$25.39K

Cash & ST Invst.

$3.97K

Total Debt

$140.00K

Tanke Biosciences Performance Analysis

Tanke Biosciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 8,430N/A
Tanke Biosciences sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-100.0%
Q42025-12-31N/A
Q12026-03-31N/A
Q22026-06-30N/A
Tanke Biosciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.01-86.1%
20232023-12-31USD -0.00-50.6%
20242024-12-31USD -0.005.1%
20252025-12-31USD -0.01163.4%
Tanke Biosciences sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-307.7%
Q42025-12-3120.8%
Q12026-03-3121.1%
Q22026-06-30-20.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$461.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$3.55K

N/A

Employees

130

N/A

Net Income

-$47.24K

+28.3%

EBITDA

-$44.59K

+28.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$3.97K

-89.4%

Total Debt

$140.00K

+0.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$140.00K

+0.0%

Return on Assets

-2.70%

N/A

Return on Invested Capital

38.11%

N/A

Free Cash Flow

-$870.00

-109.2%

Operating Cash Flow

-$869.00

-109.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IVFZFMapath Capital Corp
$0.01+0.00%
QYBXQian Yuan Baixing, Inc.
$0.01+0.00%
NGCGNew Generation Consumer Group, Inc.
$0.00-10.00%
LICHLivechain Inc.
$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$115.67+0.04%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$48.42-0.05%
IBITiShares Bitcoin Trust
$44.72+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$70.27+0.02%

Questions About TNBI

What is the current price of Tanke Biosciences?

Tanke Biosciences is trading at $0.02 per share.

What is the 52-week range for Tanke Biosciences?

Over the past 52 weeks, Tanke Biosciences has traded between $0.02 and $0.06.

How much debt does Tanke Biosciences have?

As of the most recent reporting period, Tanke Biosciences reported total debt of $140.00K.

How much cash does Tanke Biosciences have on hand?

Tanke Biosciences reported $3.97K in cash and cash equivalents in its most recent financial results.

What is Tanke Biosciences’s dividend yield?

Tanke Biosciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services